You are here

Anti-inflammation drug may also cut risk of heart disease and cancer: study

BT_20170829_NSDRUG29_3059350.jpg
Canakinumab, a drug that fights inflammation, can reduce the risk of heart attacks and strokes in people who have already had a heart attack, according to a new study.

New York

A DRUG that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.

Researchers outside the study say the findings represent a major

sentifi.com

Market voices on: